HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)
The summary for the HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required): The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.
Federal Grant Title: | HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Education Food and Nutrition Health Income Security and Social Services |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-NS-20-010 |
Type of Funding: | Grant |
CFDA Numbers: | 93.213, 93.233, 93.273, 93.286, 93.393, 93.394, 93.395, 93.399, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.859, 93.865, 93.866, 93.867 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | September 8th, 2022 |
Original Application Deadline: | September 8th, 2022 |
Posted Date: | October 4th, 2019 |
Creation Date: | October 4th, 2019 |
Archive Date: | October 14th, 2022 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | October 4th, 2019 |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding announcement for eligibility details
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-010.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
- • Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data...
- • Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01...
- • Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clin...
- • Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials o...
- • Probiotics for Pediatric Illnesses
- • Cam Practitioner Research Education Project Grant Partnership
- • Complementary and Alternative Medicine Career Transition Award (K22)
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)